Urinary endothelin-1-like immunoreactivity excretion in Wilms tumor survivors

Pediatric Nephrology, 04/24/2012

According to the authors' results, urinary endothelin (ET)–1–like Immunoreactivity (uET–1 L) seems to be a marker of glomerular injury in patients with renal mass loss revealing renal overload condition. The uET–1 L role in renal damage progression and hemodynamic glomerular worsening in nephrectomized patients should be proven by prospective long–term follow–up studies, even for potential ET–1 receptor antagonist therapeutic use.

Print Article Summary Cat 2 CME Report